2Kim JS, Yoon SS, Kim YH, et al. Serial measurement of interleukin-6,transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke,1996, 27: 1553-1557.
3Vila N, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke,2000, 31: 2325-2329.
4Albert MA, Danielson E, Rifai N, et al . Effect of therapy on C-reactive protein levels, the pravastatin inflammation/CRP evaluation (PRINCE) : a randomized trial and cohort study . JAMA,2001,286:64-70.
5Riesen WF, Engler H, Risch M, et al. Short-term effects of atorvastatin on C-reactive protein. European Heart, 2002,23:794-799.
6Yu H, Rifai N. High-sensitivity C-reactive protein and atherosclerosis:from theory to therapy.Clin Biochem, 2000, 8:601-610.
7Suzuki H, Hayashi T, Tojo SJ, et al. Anti-P-selectin antibody attenuates rat brain ischemic injury. Neurosci Lett, 1999, 265:163-166.
8Connolly ES Jr, Winfree CJ, Prestigiacomo CJ, et al. Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ Res,1997, 81:304-310.
9Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke, an independent prognostic factor. Stroke,2001, 32:917-924.
10Beamer NB, Coull BM, Clark WM, et al. Persistent inflammatory response in stroke survivors. Neurology, 1998,50:1722-1728.
